What is Arzeda?
Arzeda leverages advanced computation, including physics-based protein design and machine learning, to create and manufacture proteins that address critical global needs in food & nutrition, advanced materials, and diagnostics & pharma. By partnering with Fortune 500 companies and industrial leaders, Arzeda's proprietary platform expands the capabilities of biotechnology beyond naturally evolved solutions, driving innovation in healthy and sustainable product development worldwide.
How much funding has Arzeda raised?
Arzeda has raised a total of $91.7M across 6 funding rounds:
Series A
$15.2M
Debt
$350K
Debt
$599K
Series B
$33M
Other Financing Round
$38M
Private Equity
$4.5M
Series A (2017): $15.2M, investors not publicly disclosed
Debt (2020): $350K led by PPP
Debt (2021): $599K supported by PPP
Series B (2022): $33M featuring OS Fund, Bioeconomy Capital, Bunge Ventures, Circulate Capital, Casdin Capital, Lewis & Clark Agrifood, Conti Ventures, and UMI
Other Financing Round (2024): $38M backed by Sucden, Bunge Ventures, and Sofinnova Partners
Private Equity (2025): $4.5M, investors not publicly disclosed
Key Investors in Arzeda
OS Fund
OS Fund invests in entrepreneurs commercializing breakthrough discoveries in fields like genomics and synthetic biology, aiming to create a better future through visionary leadership and technological innovation.
Circulate Capital
Circulate Capital is an investment management firm focused on the circular economy, funding initiatives that transform recycling and plastic supply chains to deliver financial returns and positive environmental impact.
Casdin Capital
Casdin Capital brings deep expertise to financing life science innovation, with a specific focus on diagnostics and molecular information, investing in pioneers in the field.
What's next for Arzeda?
With the recent influx of major strategic investment, Arzeda is poised for significant expansion and further innovation. The company's focus on developing sustainable protein-based products, coupled with its advanced computational design platform, positions it for continued growth and market leadership. This latest financing round will likely fuel further research and development, scale manufacturing capabilities, and strengthen strategic partnerships, enabling Arzeda to address a broader range of industrial challenges and opportunities in the global bioeconomy.
See full Arzeda company page
